- Home
- AKTX vs SWIN Comparison
AKTX vs SWIN Comparison
Compare AKTX & SWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKTX
- SWIN
- Stock Information
- Founded
- AKTX N/A
- SWIN 2017
- Country
- AKTX United States
- SWIN Hong Kong
- Employees
- AKTX N/A
- SWIN N/A
- Industry
- AKTX Biotechnology: Pharmaceutical Preparations
- SWIN
- Sector
- AKTX Health Care
- SWIN
- Exchange
- AKTX Nasdaq
- SWIN Nasdaq
- Market Cap
- AKTX 29.1M
- SWIN 24.2M
- IPO Year
- AKTX N/A
- SWIN 2023
- Fundamental
- Price
- AKTX $1.45
- SWIN $1.73
- Analyst Decision
- AKTX
- SWIN
- Analyst Count
- AKTX 0
- SWIN 0
- Target Price
- AKTX N/A
- SWIN N/A
- AVG Volume (30 Days)
- AKTX 28.2K
- SWIN 81.9K
- Earning Date
- AKTX 04-16-2025
- SWIN 05-06-2025
- Dividend Yield
- AKTX N/A
- SWIN N/A
- EPS Growth
- AKTX N/A
- SWIN N/A
- EPS
- AKTX N/A
- SWIN N/A
- Revenue
- AKTX N/A
- SWIN $2,419,000.00
- Revenue This Year
- AKTX N/A
- SWIN N/A
- Revenue Next Year
- AKTX N/A
- SWIN $61.68
- P/E Ratio
- AKTX N/A
- SWIN N/A
- Revenue Growth
- AKTX N/A
- SWIN N/A
- 52 Week Low
- AKTX $0.85
- SWIN $1.16
- 52 Week High
- AKTX $4.40
- SWIN $43.60
- Technical
- Relative Strength Index (RSI)
- AKTX 64.05
- SWIN 58.06
- Support Level
- AKTX $1.03
- SWIN $1.61
- Resistance Level
- AKTX $1.58
- SWIN $1.86
- Average True Range (ATR)
- AKTX 0.16
- SWIN 0.16
- MACD
- AKTX 0.02
- SWIN 0.02
- Stochastic Oscillator
- AKTX 77.72
- SWIN 75.47
About AKTX Akari Therapeutics plc ADS
Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).
About SWIN Solowin Holdings
Solowin Holdings Ltd is a investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secured one-stop electronic platform. It is engaged in providing securities related services, investment advisory service, and asset management service to customers. The operations were organized into four reportable segments: securities related services, investment advisory services, corporate consultancy services, and asset management services. It derives maximum revenue from investment advisory services.